Matsumura, Masaru
Hasegawa, Kiyoshi http://orcid.org/0000-0001-8734-740X
Oba, Masaru
Yamaguchi, Kensei
Uetake, Hiroyuki
Yoshino, Takayuki
Morita, Satoshi
Takahashi, Keiichi
Unno, Michiaki
Shimada, Yasuhiro
Muro, Kei
Matsuhashi, Nobuhisa
Mori, Masaki
Baba, Hideo
Shimada, Mitsuo
Mise, Yoshihiro
Kawaguchi, Yoshikuni
Kagimura, Tatsuo
Ishigure, Kiyoshi
Saiura, Akio
Sugihara, Kenichi
Kokudo, Norihiro
Funding for this research was provided by:
translational research center for medical innovation in kobe
Article History
Received: 6 July 2021
Accepted: 4 January 2022
First Online: 25 February 2022
Declarations
:
: This study was approved by the institutional ethics committees of the participating institutions and was conducted in accordance with good clinical practice guidelines and the Helsinki Declaration.
: All the patients provided written informed consent.
: Consent for publication was obtained from all the patients.
: Takayuki Yoshino received lecture fee from Merck biopharma, Japan. All remaining authors declare no competing interests.